CARDINAL HEALTH INC
Company Stats
- Market Cap
- $51.7B
- as of Sep 30, 2026
- Enterprise Value
- $55.8B
- Shares Outstanding
- 231.1M
- Free Float
- 99.7%
Income Statement
- Revenue
- $254.2B
- Operating Income
- $2.6B
- Net Income
- $1.7B
- EBITDA
- $3.6B
- Non-cash Impairment
- $184.0M
- Revenue Growth, 3Y
- 7.4%
- FCF Margin, 3Y Avg
- 1.3%
- FCF Margin, Worst Year
- 0.8%
Cash Flow
- Free Cash Flow
- $4.5B
- FCF Yield
- 8.7%
- Owner FCF Yield
- 8.0%
Balance Sheet
- Cash & Equivalents
- $4.9B
- Total Debt
- $8.9B
- Net Debt
- $4.0B
- Net Debt / EBITDA
- 1.13x
- EV / EBITDA
- 15.63x
- Net Debt / EBIT
- 1.54x
Returns & Capital
- Dividends Paid
- $491.0M
- Dividend Yield
- 0.9%
- Dividend Payout, 3Y Avg
- 39.6%
- Share Repurchases
- $1.4B
- Buyback Yield, 3Y Avg
- 1.9%
- SBC, 3Y Avg
- $244.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2026 | $254.2B | $4.5B | 1.8% |
| FY2025 | $222.6B | $1.9B | 0.8% |
| FY2024 | $226.8B | $3.3B | 1.4% |
| FY2023 | $205.0B | $2.4B | 1.2% |
| FY2022 | $181.3B | $2.8B | 1.5% |
Annual filing data through FY ended June 30, 2026; shares and float as of November 8, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Chipmakers Lead a Guidance Season Almost Free of Cuts